Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,300 | 12,030 |
| Depreciation Amortization | 780 | 700 |
| Other Working Capital | 47,410 | -16,670 |
| Other Operating Activity | 1,680 | 620 |
| Operating Cash Flow | $45,570 | $-3,320 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -510 | -140 |
| Other Investing Activity | 1,000 | -11,330 |
| Investing Cash Flow | $490 | $-11,470 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | -4,390 |
| Financing Cash Flow | $0 | $-4,390 |
| Exchange Rate Effect | 170 | -3,020 |
| Beginning Cash Position | 13,920 | 60,160 |
| End Cash Position | 60,160 | 37,950 |
| Net Cash Flow | $46,230 | $-22,210 |
| Free Cash Flow | ||
| Operating Cash Flow | 45,570 | -3,320 |
| Free Cash Flow | 45,570 | -3,320 |